Εγγραφείτε για να δημιουργήσετε ειδοποιήσεις για Οικονομικά Στοιχεία,
Οικονομικά Γεγονότα και περιεχόμενο από τους αρθρογράφους που ακολουθείτε
Δωρεάν Εγγραφή Έχετε ήδη λογαριασμό; Σύνδεση
Προσφορές
Όλοι οι τύποι
- Όλοι οι τύποι
- Δείκτες
- Μετ/κού Κεφαλαίου
- ETF
- Κεφάλαια
- Εμπορ/τα
- Νομίσματα
- Crypto
- Ομόλογα
- Πιστοποιητικά
Δοκιμάστε άλλη αναζήτηση
🔥 Η στρατηγική της AI μας, Τεχνολογικοί Γίγαντες είναι πάνω + 7,1% ως τώρα τον Μάιο.
Μπες στη δράση ενώ οι μετοχές είναι ΚΑΥΤΕΣ.
Μπες στη δράση ενώ οι μετοχές είναι ΚΑΥΤΕΣ.
Εξαργυρώστε ΕΚΠΤΩΣΗ 40%
Janus Henderson Global Life Sciences Fund Class D (JNGLX)
Προσθήκη/Αφαίρεση από το χαρτοφυλάκιο
Προσθήκη στο Χαρτοφυλάκιο
74,34
-0,28
-0,38%
- Βαθμολογία Morningstar:
- Σύν. Ενεργ.: 1,76B
Janus Global Life Sciences D
74,34
-0,28
-0,38%
Επισκόπηση JNGLX
Σε αυτή τη σελίδα θα βρεις ένα εις βάθος προφίλ για το Janus Henderson Global Life Sciences Fund Class D. Μάθε μεταξύ άλλων για τα βασικά διοικητικά στελέχη, το σύνολο του ενεργητικού, τη στρατηγική για τις επενδύσεις και τα στοιχεία επικοινωνίας για το JNGLX.
Πληροφορίες Συνδέσμου
Διεύθυνση
151 Detroit Street
Denver,CO 80206
United States
Denver,CO 80206
United States
Τηλέφωνο
+1 8773352687
Διαδίκτυο
janushenderson.com
Διοικητικά Στελέχη
| Όνομα | Τίτλος | Από | Μέχρι |
|---|---|---|---|
| Daniel Lyons | Portfolio Manager | 2023 | now |
| Βιογραφία | "Daniel Lyons is a Portfolio Manager and Research Analyst at Janus Henderson Investors responsible for co-managing the Biotechnology strategy since 2018. Daniel started consulting for Janus in 1997 and joined the Health Care Sector Research Team full time in 2000. As a research analyst, he focuses on the biotechnology and life science tools sectors. Daniel received his bachelor of arts degree in biochemistry and chemistry from Rice University, graduating magna cum laude. He also earned a PhD from Stanford University’s programme in immunology and conducted postdoctoral research with a Nobel Laureate at the University of Colorado. He holds the Chartered Financial Analyst designation and has 19 years of financial industry experience." | ||
| Andy Acker | Portfolio Manager | 2007 | now |
| Βιογραφία | "Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience." | ||
| Ethan Lovell | Portfolio Manager | 2016 | 2019 |
| Βιογραφία | Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Ethan Lovell is a Portfolio Manager at Janus Henderson Investors, responsible for co-managing the Global Life Sciences strategy, a position he has held since 2016. Prior to this, Mr. Lovell served as assistant portfolio manager on the strategy. He is also a Research Analyst, primarily focusing on the global pharmaceutical and medical device industries. Before joining Janus in 2007 as a research analyst, Mr. Lovell was a director at ClearBridge Advisors, covering companies in the pharmaceutical, biotechnology and medical device industries. Previously, he was managing director and founding partner of Saranac Capital, LP, where he was the health care sector portfolio manager. Mr. Lovell also worked at Salomon Brothers Asset Management as a director and later managing director of the health care team. He began his career at Bear, Stearns & Co. as an equity research analyst covering biotechnology, pharmaceuticals and life science tool companies. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. He has 24 years of financial industry experience. Mr. Lovell received his bachelor of arts degree, with a double major in chemistry and economics, from Bowdoin College and his MBA from Tulane University. | ||
| Thomas R. Malley | Portfolio Manager | 1998 | 2007 |
| Βιογραφία | Malley joined Janus Capital Corporation in 1991 and currently serves as a portfolio manager. Malley holds the Chartered Financial Analyst designation. | ||
| Andy Acker | Portfolio Manager | 2006 | 2007 |
| Βιογραφία | "Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience." | ||
Γράψτε τις σκέψεις σας για τo Janus Henderson Global Life Sciences Fund Class D
Σίγουρα θέλετε να διαγράψετε αυτό το διάγραμμα;
Διαγραφή Ακύρωση
Αντικατάσταση του επισυναπτόμενου διαγράμματος με νέο;
Αντικατάσταση Ακύρωση
Οδηγίες σχολιασμού
Επισύναψη Διαγράμματος στο Σχόλιο
Επιβεβαίωση μπλοκαρίσματος
Είστε σίγουροι πώς θέλετε να μπλοκάρετε τον/την %USER_NAME%;
Με αυτή την ενέργεια, εσείς και ο/η %USER_NAME% δεν θα μπορείτε να δείτε ο ένας τις αναρτήσεις του άλλου στο Investing.com.
Ο/Η %USER_NAME% προστέθηκε επιτυχώς στη λίστα μπλοκαρίσματός σας
Επειδή έχετε μόλις ξεμπλοκάρει αυτό το άτομο θα πρέπει να περιμένετε 48 ώρες πριν μπορέσετε να τον ξαναμπλοκάρετε.
Αναφορά προβλήματος
Πείτε μας τη γνώμη σας γι' αυτό το σχόλιο
Το σχόλιο σημειώθηκε
Σας Ευχαριστούμε!
Η αναφορά σας στάλθηκε στους επόπτες για επιθεώρηση